“…Thus, in order to develop a preferred solid dosage form, the nano-suspension must be transformed into a solid product, presenting additional challenges. Five products (Rapamune®, Emend®, TriCor®, Megace®ES, and Triglide™ (13,16)) produced via nanoparticle technology are currently available in the market, of which four are based on the media milling technique (Elan NanoCrystal® technology (13,14,16)). The remaining one (Triglide™) is manufactured using high-pressure homogenization (DissoCubes®, SkyePharma PLC (17)) and requires several steps, including freeze-drying, spray-drying, spray coating, and pelletizing or granulation, to convert the nanoparticles in a solid powder (18) for compaction into tablets or filling into capsules.…”